Lhcgr expression in granulosa cells: Roles for PKA-phosphorylated β-catenin, TCF3, and FOXO1

Molecular Endocrinology

Volumn 27, Issue 8, 2013, Pages 1295-1310

  Law, Nathan C ^a   Weck, Jennifer ^a   Kyriss, Brandon ^a   Nilson, John H ^a   Hunzicker Dunn, Mary ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA CATENIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; FOLLITROPIN; LUCIFERASE; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STEROIDOGENIC FACTOR 1; TRANSCRIPTION FACTOR 7 LIKE 1; TRANSCRIPTION FACTOR FKHR;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GRANULOSA CELL; HORMONE ACTION; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR GENE; REPORTER GENE;

ANIMALS; BETA CATENIN; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; FEMALE; FOLLICLE STIMULATING HORMONE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GRANULOSA CELLS; NERVE TISSUE PROTEINS; OVARIAN FOLLICLE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GONADOTROPIN; RECEPTORS, LH; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEROIDOGENIC FACTOR 1; TRANSCRIPTION FACTOR 7-LIKE 1 PROTEIN; TRANSFECTION;

EID: 84880799266     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1025     Document Type: Article

References (68)

1. George JW, Dille EA, Heckert LL. Current concepts of folliclestimulating hormone receptor gene regulation. Biol Reprod. 2011; 84:7-17.
2. Hsueh AJ, Rauch R. Ovarian Kaleidoscope database: ten years and beyond. Biol Reprod. 2012;86:192.
3. Escamilla-Hernandez R, Little-Ihrig L, Orwig KE, Yue J, Chandran U, Zeleznik AJ. Constitutively active protein kinase A qualitatively mimics the effects of follicle-stimulating hormone on granulosa cell differentiation. Mol Endocrinol. 2008;22:1842-1852.
4. Zeleznik AJ, Midgley AR Jr, Reichert LE Jr. Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. Endocrinology. 1974;95:818-825.
5. Dierich A, Sairam MR, Monaco L, et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA. 1998;95:13612-13617.
6. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol. 2001;15:172-183.
7. McFarland KC, Sprengel R, Phillips HS, et al. Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science. 1989;245:494-499.
8. Shi H, Segaloff DL. A role for increased lutropin/choriogonadotropin receptor (LHR) gene transcription in the follitropin-stimulated induction of the LHR in granulosa cells. Mol Endocrinol. 1995;9: 734-744.
9. Hunzicker-Dunn M, Maizels ET. FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal. 2006;18:1351-1359.
10. Chen S, Shi H, Liu X, Segaloff DL. Multiple elements and protein factors coordinate the basal and cyclic adenosine 3',5' -monophosphate- induced transcription of the lutropin receptor gene in rat granulosa cells. Endocrinology. 1999;140:2100-2109.
11. Nikula H, Koskimies P, El-Hefnawy T, Huhtaniemi I. Functional characterization of the basal promoter of the murine LH receptor gene in immortalized mouse Leydig tumor cells. J Mol Endocrinol. 2001;26:21-29.
12. Tsai-Morris CH, Xie X, Wang W, Buczko E, Dufau ML. Promoter and regulatory regions of the rat luteinizing hormone receptor gene. J Biol Chem. 1993;268:4447-4452.
13. Tsai-Morris CH, Geng Y, Buczko E, Dufau ML. Characterization of diverse functional elements in the upstream Sp1 domain of the rat luteinizing hormone receptor gene promoter. J Biol Chem. 1995; 270:7487-7494.
14. Chen S, Liu X, Segaloff DL. A novel cyclic adenosine 3',5' -monophosphate- responsive element involved in the transcriptional regulation of the lutropin receptor gene in granulosa cells. Mol Endocrinol. 2000;14:1498-1508.
15. Dufau ML, Liao M, Zhang Y. Participation of signaling pathways in the derepression of luteinizing hormone receptor transcription. Mol Cell Endocrinol. 2010;314:221-227.
16. Zhang Y, Dufau ML. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. J Biol Chem. 2002;277:33431-33438.
17. Zhang Y, Liao M, Dufau ML. Phosphatidylinositol 3-kinase/protein kinase C' -induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene. Mol Cell Biol. 2006;26:6748-6761.
18. Zhang Y, Liao M, Dufau ML. Unlocking repression of the human luteinizing hormone receptor gene by trichostatin A-induced cellspecific phosphatase release. J Biol Chem. 2008;283:24039-24046.
19. Liao M, Zhang Y, Dufau ML. Protein kinase C+-induced derepression of the human luteinizing hormone receptor gene transcription through ERK-mediated release of HDAC1/Sin3A repressor complex from Sp1 sites. Mol Endocrinol. 2008;22:1449-1463.
20. Hunzicker-Dunn ME, Lopez-Biladeau B, Law NC, Fiedler SE, Carr DW, Maizels ET. PKA and GAB2 play central roles in the FSH signaling pathway to PI3K and AKT in ovarian granulosa cells. Proc Natl Acad Sci USA. 2012;109:E2979-E2988.
21. Tetsu O, McCormick F. β -Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422-426.
22. Meeks JJ, Crawford SE, Russell TA, Morohashi K, Weiss J, Jameson JL. Dax1 regulates testis cord organization during gonadal differentiation. Development. 2003;130:1029-1036.
23. Alam H, Maizels ET, Park Y, et al. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J Biol Chem. 2004;279:19431-19440.
24. Parakh TN, Hernandez JA, Grammer JC, et al. Follicle-stimulating hormone/cAMP regulation of aromatase gene expression requires beta-catenin. Proc Natl Acad Sci USA. 2006;103:12435-12440.
25. Salisbury TB, Binder AK, Grammer JC, Nilson JH. GnRH-regulated expression of Jun and JUN target genes in gonadotropes requires a functional interaction between TCF/LEF family members and β -catenin. Mol Endocrinol. 2009;23:402-411.
26. Park Y, Maizels ET, Feiger ZJ, et al. Induction of cyclin D2 in rat granulosa cells requires FSH-dependent relief from FOXO1 repression coupled with positive signals from Smad. J Biol Chem. 2005; 280:9135-9148.
27. Saxena D, Safi R, Little-Ihrig L, Zeleznik AJ. Liver receptor homolog- 1 stimulates the progesterone biosynthetic pathway during follicle-stimulating hormone-induced granulosa cell differentiation. Endocrinology. 2004;145:3821-3829.
28. Weck J, Mayo KE. Switching of NR5A proteins associated with the inhibin β -subunit gene promoter after activation of the gene in granulosa cells. Mol Endocrinol. 2006;20:1090-1103.
29. Duan WR, Ito M, Park Y, Maizels ET, Hunzicker-Dunn M, Jameson JL. GnRH regulates early growth response protein 1 transcription through multiple promoter elements. Mol Endocrinol. 2002; 16:221-233.
30. Bain J, Plater L, Elliott M, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007;408:297-315.
31. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;351:95-105.
32. Cheng HC, Kemp BE, Pearson RB, et al. A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem. 1986;261:989-992.
33. Clemens JW, Lala DS, Parker KL, Richards JS. Steroidogenic factor- 1 binding and transcriptional activity of the cholesterol sidechain cleavage promoter in rat granulosa cells. Endocrinology. 1994;134:1499-1508.
34. Falender AE, Lanz R, Malenfant D, Belanger L, Richards JS. Differential expression of steroidogenic factor-1 and FTF/LRH-1 in the rodent ovary. Endocrinology. 2003;144:3598-3610.
35. Jeyasuria P, Ikeda Y, Jamin SP, et al. Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol Endocrinol. 2004;18:1610-1619.
36. Hanley NA, Ikeda Y, Luo X, Parker KL. Steroidogenic factor 1 (SF-1) is essential for ovarian development and function. Mol Cell Endocrinol. 2000;163:27-32.
37. Ito M, Park Y, Weck J, Mayo KE, Jameson JL. Synergistic activation of the inhibin α -promoter by steroidogenic factor-1 and cyclic adenosine 3',5'-monophosphate. Mol Endocrinol. 2000;14:66-81.
38. Carlone DL, Richards JS. Functional interactions, phosphorylation, and levels of 3',5' -cyclic adenosine monophosphate-regulatory element binding protein and steroidogenic factor-1 mediate hormone-regulated and constitutive expression of aromatase in gonadal cells. Mol Endocrinol. 1997;11:292-304.
39. Monté D, DeWitte F, Hum DW. Regulation of the human P450scc gene by steroidogenic factor 1 is mediated by CBP/p300. J Biol Chem. 1998;273:4585-4591.
40. Kennell JA, O'Leary EE, Gummow BM, Hammer GD, MacDougald OA. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with β -catenin to coactivate C/EBP+ and steroidogenic factor 1 transcription factors. Mol Cell Biol. 2003;23:5366-5375.
41. Gummow BM, Winnay JN, Hammer GD. Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin α gene. J Biol Chem. 2003;278:26572-26579.
42. Mizusaki H, Kawabe K, Mukai T, et al. Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene transcription is regulated by Wnt4 in the female developing gonad. Mol Endocrinol. 2003;17:507-519.
43. Jordan BK, Shen JH, Olaso R, Ingraham HA, Vilain E. Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/β-catenin synergy. Proc Natl Acad Sci USA. 2003;100:10866-10871.
44. Salisbury TB, Binder AK, Grammer JC, Nilson JH. Maximal activity of the luteinizing hormone β -subunit gene requires β -catenin. Mol Endocrinol. 2007;21:963-971.
45. Arce L, Yokoyama NN, Waterman ML. Diversity of LEF/TCF action in development and disease. Oncogene. 2006;25:7492-7504.
46. MacDonald BT, Tamai K, He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9-26.
47. Fan HY, O'Connor A, Shitanaka M, Shimada M, Liu Z, Richards JS. β-catenin (CTNNB1) promotes preovulatory follicular development but represses LH-mediated ovulation and luteinization. Mol Endocrinol. 2010;24:1529-1542.
48. Yochum GS, Cleland R, Goodman RH. A genome-wide screen for β -catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression. Mol Cell Biol. 2008;28:7368-7379.
49. Taurin S, Sandbo N, Qin Y, Browning D, Dulin NO. Phosphorylation of β-catenin β -catenin by cyclic AMP-dependent protein kinase. J Biol Chem. 2006;281:9971-9976.
50. Taurin S, Sandbo N, Yau DM, Sethakorn N, Dulin NO. Phosphorylation of β-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells. Am J Physiol Cell Physiol. 2008;294: C1169-C1174.
51. Hino S, Tanji C, Nakayama KI, Kikuchi A. Phosphorylation of β-catenin by cyclic AMP-dependent protein kinase stabilizes β-catenin through inhibition of its ubiquitination. Mol Cell Biol. 2005;25:9063-9072.
52. Fang D, Hawke D, Zheng Y, et al. Phosphorylation of β -catenin by AKT promotes β -catenin transcriptional activity. J Biol Chem. 2007;282:11221-11229.
53. Liu Z, Rudd MD, Hernandez-Gonzalez I, et al. FSH and FOXO1 regulate genes in the sterol/steroid and lipid biosynthetic pathways in granulosa cells. Mol Endocrinol. 2009;23:649-661.
54. Van Der Heide LP, Hoekman MF, Smidt MP. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J. 2004;380:297-309.
55. Alam H, Weck J, Maizels E, et al. Role of the phosphatidylinositol- 3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone. Endocrinology. 2009; 150:915-928.
56. Bennett J, Wu YG, Gossen J, Zhou P, Stocco C. Loss of GATA-6 and GATA-4 in granulosa cells blocks folliculogenesis, ovulation, and follicle stimulating hormone receptor expression leading to female infertility. Endocrinology. 2012;153:2474-2485.
57. Ascoli M, Fanelli F, Segaloff DL. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev. 2002;23:141-174.
58. Cinnamon E, Paroush Z. Context-dependent regulation of Groucho/TLE-mediated repression. Curr Opin Genet Dev. 2008; 18:435-440.
59. Fang X, Yu SX, Lu Y, Bast RC Jr, Woodgett JR, Mills GB. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA. 2000;97:11960-11965.
60. Pearce LR, Komander D, Alessi DR. The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol. 2010;11:9-22.
61. Kikuchi A, Kishida S, Yamamoto H. Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med. 2006;38:1-10.
62. Boyer A, Lapointe E, Zheng X, et al. WNT4 is required for normal ovarian follicle development and female fertility. FASEB J. 2010; 24:3010-3025.
63. Boerboom D, Paquet M, Hsieh M, et al. Misregulated Wnt/ β-- catenin signaling leads to ovarian granulosa cell tumor development. Cancer Res. 2005;65:9206-9215.
64. Little TH, Zhang Y, Matulis CK, et al. Sequence-specific deoxyribonucleic acid (DNA) recognition by steroidogenic factor 1: a helix at the carboxy terminus of theDNAbinding domain is necessary for complex stability. Mol Endocrinol. 2006;20:831-843.
65. Ito M, Yu RN, Jameson JL. Steroidogenic factor-1 contains a carboxy- terminal transcriptional activation domain that interacts with steroid receptor coactivator-1. Mol Endocrinol. 1998;12:290-301.
66. Børud B, Hoang T, Bakke M, Jacob AL, Lund J, Mellgren G. The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1. Mol Endocrinol. 2002;16:757-773.
67. Hammer GD, Krylova I, Zhang Y, et al. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol Cell. 1999;3: 521-526.
68. Saxena D, Escamilla-Hernandez R, Little-Ihrig L, Zeleznik AJ. Liver receptor homolog-1 and steroidogenic factor-1 have similar actions on rat granulosa cell steroidogenesis. Endocrinology. 2007; 148:726-734.